Tag: chronic pain

Spinal cord stimulation and chronic pain: In the end it’s about...

Krishnan Chakravarthy writes in NeuroNews about how spinal cord stimulation can be used to treat chronic pain and how this can help America overcome...

Neurostimulation can be part of the solution to the opioid crisis

The president of the United States of America has recently declared the opioid crisis in that country a “public health emergency”. In light of...

Innovation. Outcomes. Focus on Function.

Medtronic has a long-standing commitment to delivering innovative pain stimulation technology and building the evidence that matters today and leads us into the future. This is again...
Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

WHISPER SCS study: therapy optimisation associated with more effective pain relief

New data from the WHISPER randomised controlled trial (RCT) have demonstrated that patients who are given the choice to use both sub-perception and paraesthesia-based...

Spectra WaveWriter Spinal Cord Stimulator System receives FDA approval

The Spectra WaveWriter Spinal Cord Stimulator (SCS) System (Boston Scientific) has received FDA approval. It is the first and only system approved by the...
Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

FDA approves Senza II Spinal Cord Stimulation System

The US Food and Drug Administration has approved the next-generation Senza II Spinal Cord Stimulation (SCS) System (Nevro) delivering HF10 therapy. According to the company,...
Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

FDA approves new clinician programmer for SynchroMed II intrathecal drug delivery...

The US Food and Drug Administration (FDA) has approved a new clinician programmer for use with the SynchroMed II Intrathecal Drug Delivery system (Medtronic),...

First patient enrolled in study to assess optimised spinal cord stimulation...

The first patient has been enrolled in the Vectors Post Market Clinical Study. The study will follow patients with chronic intractable pain who are...

StimRouter Neuromodulation System eligible for increased Medicare reimbursements

  The Centers for Medicare & Medicaid Service (CMS) has approved significantly larger payment rates for the StimRouter Neuromodulation System (Bioness) in the Hospital Outpatient...

Radiofrequency treatment provides pain relief in new study

A study presented at the annual meeting of the Radiological Society of North America (RSNA, 26 November-1 December, Chicago, USA) has found that the...

NANS responds to California DWC order to discontinue coverage of non-opioid...

The North American Neuromodulation Society (NANS) has issued a response to the California Division of Workers’ Compensation (DWC) order which adopts regulations to update the evidence-based...

Nevro receives CE mark for full-body MRI conditional labelling with the...

Nevro has received the CE mark for full-body magnetic resonance imaging (MRI) conditional labelling on the Senza Spinal Cord Stimulation (SCS) System delivering HF10...

Intellis platform receives CE mark for spinal cord and peripheral nerve...

Medtronic has received CE mark for the Intellis platform for both spinal cord stimulation (SCS) and peripheral nerve stimulation (PNS) as an aid in...
Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

Closed-loop spinal cord stimulation may represent new paradigm to mitigate tolerance

With six-month follow-up indicating that dorsal column activation is regulated to therapeutic levels by closed-loop spinal cord stimulation (SCS) using evoked compound action potentials...

FDA approves Intellis platform for chronic pain

The US Food and Drug Administration has approved the Intellis spinal cord stimulation platform (Medtronic) for the management of certain types of chronic intractable...

Evidence in favour of DRG stimulation builds with real-world data

The real-world data collected in the PREDICT study has added to the evidence in favour of dorsal root ganglion (DRG) stimulation for the management...
Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

No difference in pain relief between 1kHz and 10kHz spinal cord...

A randomised controlled trial has found excellent pain relief and no clinical difference among spinal cord stimulation frequencies from 1kHz–10kHz. Further, the study showed...

US FDA clears Stimwave’s full-body MRI-ready wireless peripheral nerve stimulator

Stimwave has received US Food and Drug Administration (FDA) 510(k) clearance for the first wireless, micro-technology neuromodulation device that can enable ongoing full-body MRI...
Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

DBS for chronic neuropathic pain efficacious at three years’ follow-up

A study published in the journal Neuromodulation has shown efficacy at three years’ follow-up for deep brain stimulation (DBS) for the treatment of neuropathic...

FDA clears Stimpod NMS460 non-invasive neuromodulation device

The US Food and Drug Administration (FDA) has cleared the Stimpod NMS460 (Xavant Technology). With the US patent awarded on proprietary hybrid pulsed radio...
Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

Marking 50 years of spinal cord stimulation

The year 2017 marks the 50th anniversary for spinal cord stimulation therapy which was first used to treat pain in 1967. To celebrate the...

Saluda Medical secures US$40 million in series D financing

Saluda Medical, a medical device company developing a platform of closed-loop neuromodulation technologies based on neural response to stimulation, has secured US$40 million in...

CE mark approval for Stimwave’s world-first fully percutaneous spinal cord stimulator...

CE mark approval has been granted for the world’s first percutaneous injectable anchor system, SandShark. The Stimwave system is used to fixate the company’s...
Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

Higher trial-to-implant ratio found at high-volume SCS centres

A study carried out by Kelly Ryan Murphy (Duke University Medical Center, Durham, USA) and colleagues has found that centres with high-volume spinal cord...
Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

Prospective study shows good efficacy with high-frequency spinal cord stimulation in...

A study published in the journal Neuromodulation reports good efficacy with high-frequency spinal cord stimulation with notable reductions on the numerical rating scale back...
Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

Low-profile multicolumn paddle lead improves access to spinal canal

A low-profile multicolumn paddle lead has provided an option for spinal cord stimulation therapy in an area which traditionally is difficult to access with...
Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

Individualised patient care the future of SCS

A multicentre, double-blind, randomised and placebo-controlled crossover trial has found that patients with complex regional pain syndrome (CRPS) show preference for different spinal cord...
Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

More research needed to show potential of neuromodulation

While much has been done in the past decade to advance the field of neuromodulation, some investigators believe only small steps have been made...

Spinal cord stimulation reduces or stabilises opioid use among chronic pain...

New research has found spinal cord stimulation therapy can reduce or stabilise the use of opioids in patients battling chronic pain. Researchers examined opioid...

Proclaim DRG Neurostimulation System introduced in Europe

Abbott has announced the European launch of the new Proclaim DRG Neurostimulation System, designed to deliver dorsal root ganglion (DRG) stimulation to patients suffering...

ACCURATE 12-month data published in Pain

New data published in the January edition of Pain has confirmed the superiority of dorsal root ganglion (DRG) stimulation therapy (from Abbott) over traditional...

Nuvectra picks up New Product Innovation Award for SCS device

Based on its recent analysis of the spinal cord stimulation (SCS) market, Frost & Sullivan has recognised Nuvectra with the 2017 North American New...
Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

New guidance on neuromodulation therapy to be published

The International Neuromodulation Society (INS) journal Neuromodulation: Technology at the Neural Interface is publishing expert, evidence-based guidance on the safe and efficient use of neuromodulation implants in patient-centred...

CE mark for full body MR conditional labelling for Proclaim Elite...

The Proclaim Elite spinal cord stimulation (SCS) system (St Jude Medical) has received CE mark approval for full-body magnetic resonance (MR) conditional labelling. With...

CE mark for Quell wearable pain relief device

NeuroMetrix has received CE mark for the Quell wearable pain relief device. This certification in the European Union allows sales and marketing of Quell...

Proclaim Elite spinal cord stimulation system earns full-body MRI compatibility labelling

The US Food and Drug Administration (FDA) has approved full-body magnetic resonance (MR) conditional labelling for the Proclaim Elite spinal cord stimulation (SCS) system (St Jude Medical)....

Southeast Pain Care uses new Axium neurostimulator for chronic pain

Southeast Pain Care is one of the first facilities in North Carolina, USA, to use a new neurostimulation device designed to relieve the sensation...

FDA approves BurstDR stimulation for patients with chronic pain

The US Food and Drug Administration (FDA) has approved BurstDR stimulation, a physician-designed form of spinal cord stimulation (SCS) clinically proven to provide superior outcomes for...

Study urges earlier consideration of spinal cord stimulation in chronic pain...

A study recently published in the journal Neuromodulation suggests that earlier consideration of spinal cord stimulation in chronic pain care continuum could have a...

SCS TechTalk: Innovation Starts Here

In this Boston Scientific Educational Supplement, you will read about the pace of innovation—from delivering the first and only rechargeable spinal cord stimulation (SCS) system powered by intuitive...

Two year SENZA-RCT results demonstrate sustained superiority of high-frequency 10 therapy...

Two-year SENZA-RCT results have been published in Neurosurgery, according to Nevro.  The SENZA-RCT is a pivotal study that is both the largest prospective randomised...

Most patients with chronic trunk or limb pain experience “substantial” pain...

Twenty-four month data from a postmarket, clinical registry have found that most patients suffering from chronic pain of the trunk and/or limbs reported “substantial”...

Nuvectra reports first quarter financial results

Nuvectra has announced the company’s financial results for the first quarter of 2016. According to a press release, total revenue in the first quarter of...

First US commercial implants of Axium DRG system announced

St Jude Medical has announced the US launch and first post-approval implants of the St Jude Medical Axium Neurostimulator System for dorsal root ganglion (DRG) stimulation...

St. Jude Medical: Returning innovation to chronic pain treatment

With a series of acquisitions and recent product approvals, St. Jude Medical has further solidified its place as a leading provider of treatment options...

High-density stimulation restores efficacy in failed spinal cord stimulation therapy

By reprogramming existing spinal cord stimulation systems, investigators have been able to restore efficacy in patients who have failed spinal cord stimulation therapy, and...

SUNBURST data demonstrates superior pain relief results for Burst Stimulation over...

St Jude Medical’s Burst stimulation can relieve chronic pain more effectively than traditional tonic spinal cord stimulation (SCS), according to the SUNBURST study. The...

St Jude Medical launches spinal cord stimulation system in Europe

St Jude Medical has launched its Proclaim Elite spinal cord stimulation (SCS) system in Europe. According to a press release, this is the world’s...

FDA approves Proclaim Elite SCS System

St Jude Medical has announced FDA approval of the new Proclaim Elite Spinal Cord Stimulation System, the first and only upgradeable and recharge-free spinal cord stimulation (SCS)...

St Jude Medical receives CE mark for MRI conditional labelling of...

St Jude Medical has received CE mark approval for magnetic resonance imaging (MRI) conditional labelling for the company’s Prodigy MRI chronic pain system with...